{"AllianceGenome": "8582", "HGNC": "8582", "MIM": "612349", "_id": "5053", "_version": 1, "accession": {"genomic": ["AB778766.1", "AC026108.29", "AC069227.24", "AF003965.1", "AF003967.1", "AF404777.1", "AY563525.1", "AY722625.1", "AY722626.1", "AY722627.1", "CH471054.1", "CP068266.2", "LC611730.1", "NC_000012.12", "NC_060936.1", "NG_008690.2", "S75697.1", "S75702.1", "S75704.1", "S76376.1", "S83538.2"], "protein": ["AAA60082.1", "AAA80910.1", "AAB50813.1", "AAC51772.1", "AAD13926.1", "AAD13928.1", "AAD14181.1", "AAD14183.1", "AAD14184.1", "AAH26251.1", "AAL78816.1", "AAS66667.1", "AAU11304.1", "AAU11305.1", "AAU11306.1", "BAG36181.1", "BAG60644.1", "BAN63795.1", "EAW97700.1", "EAW97701.1", "EAW97702.1", "NP_000268.1", "NP_001341233.1", "P00439.1", "XP_016874859.1", "XP_054228125.1"], "rna": ["AK298419.1", "AK313383.1", "BC026251.1", "BQ268294.1", "DA299598.1", "K03020.1", "L47726.1", "NM_000277.3", "NM_001354304.2", "S61296.1", "S61396.1", "U49897.1", "XM_017019370.2", "XM_054372150.1"], "translation": [{"protein": "AAD13926.1", "rna": "S61296.1"}, {"protein": "AAD13928.1", "rna": "S61396.1"}, {"protein": "AAH26251.1", "rna": "BC026251.1"}, {"protein": "AAC51772.1", "rna": "U49897.1"}, {"protein": "XP_054228125.1", "rna": "XM_054372150.1"}, {"protein": "BAG36181.1", "rna": "AK313383.1"}, {"protein": "NP_001341233.1", "rna": "NM_001354304.2"}, {"protein": "BAG60644.1", "rna": "AK298419.1"}, {"protein": "AAA60082.1", "rna": "K03020.1"}, {"protein": "NP_000268.1", "rna": "NM_000277.3"}, {"protein": "AAA80910.1", "rna": "L47726.1"}, {"protein": "XP_016874859.1", "rna": "XM_017019370.2"}]}, "alias": ["PH", "PKU", "PKU1"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2020-04-24T16:00:00.000Z", "disease_label": "phenylketonuria", "gcep": "Aminoacidopathy Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0009861", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_5a617cb4-94ec-4f34-b97e-10d9808a1581-2020-04-24T160000.000Z", "sop": "SOP7"}}, "ec": "1.14.16.1", "ensembl": {"gene": "ENSG00000171759", "protein": ["ENSP00000303500", "ENSP00000446658", "ENSP00000447620", "ENSP00000448059", "ENSP00000489016", "ENSP00000489230"], "transcript": ["ENST00000307000", "ENST00000546708", "ENST00000546844", "ENST00000547319", "ENST00000548677", "ENST00000548928", "ENST00000549111", "ENST00000549247", "ENST00000550405", "ENST00000550978", "ENST00000551114", "ENST00000551337", "ENST00000551988", "ENST00000552251", "ENST00000553106", "ENST00000635477", "ENST00000635500", "ENST00000635528"], "translation": [{"protein": "ENSP00000448059", "rna": "ENST00000553106"}, {"protein": "ENSP00000303500", "rna": "ENST00000307000"}, {"protein": "ENSP00000489230", "rna": "ENST00000635477"}, {"protein": "ENSP00000489016", "rna": "ENST00000550978"}, {"protein": "ENSP00000447620", "rna": "ENST00000551337"}, {"protein": "ENSP00000446658", "rna": "ENST00000546844"}], "type_of_gene": "protein_coding"}, "entrezgene": "5053", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 22.7041593659, "exp_mis": 147.808010031, "exp_syn": 58.9643532194, "lof_z": 0.977955300084952, "mis_z": -1.53652594118042, "mu_lof": 1.53695791301e-06, "mu_mis": 1.26302887786e-05, "mu_syn": 4.7550810356e-06, "n_lof": 18.0, "n_mis": 186.0, "n_syn": 64.0, "p_li": 1.19519744629961e-10, "p_null": 0.692551334801337, "p_rec": 0.307448665079143, "syn_z": -0.406546522158672}, "bp": 1359, "cds_end": 103310908, "cds_start": 103232952, "n_exons": 13, "nonpsych": {"exp_lof": 20.2832015413, "exp_mis": 133.514261933, "exp_syn": 53.1021768402, "lof_z": 0.93401150084635, "mis_z": -1.50534773821518, "mu_lof": 1.53695791301e-06, "mu_mis": 1.26302887786e-05, "mu_syn": 4.7550810356e-06, "n_lof": 16.0, "n_mis": 168.0, "n_syn": 58.0, "p_li": 1.75375723417441e-09, "p_null": 0.640070225489126, "p_rec": 0.359929772757117, "syn_z": -0.423165376241366}, "nontcga": {"exp_lof": 20.8618745794, "exp_mis": 135.957425738, "exp_syn": 54.2212552042, "lof_z": 1.05004588755935, "mis_z": -1.58273939585943, "mu_lof": 1.53695791301e-06, "mu_mis": 1.26302887786e-05, "mu_syn": 4.7550810356e-06, "n_lof": 16.0, "n_mis": 173.0, "n_syn": 61.0, "p_li": 2.47569166869872e-09, "p_null": 0.550031325214496, "p_rec": 0.449968672309812, "syn_z": -0.582889810885122}, "transcript": "ENST00000553106.1"}, "exons": [{"cdsend": 102917130, "cdsstart": 102839174, "chr": "12", "position": [[102836888, 102839218], [102840399, 102840515], [102843645, 102843779], [102844335, 102844431], [102846894, 102846951], [102851686, 102851756], [102852814, 102852950], [102855135, 102855332], [102866595, 102866663], [102877461, 102877550], [102894734, 102894918], [102912790, 102912898], [102917070, 102917244]], "strand": -1, "transcript": "NM_000277", "txend": 102917244, "txstart": 102836888}, {"cdsend": 102917130, "cdsstart": 102839174, "chr": "12", "position": [[102836888, 102839218], [102840399, 102840515], [102843645, 102843779], [102844335, 102844431], [102846894, 102846951], [102851686, 102851756], [102852814, 102852950], [102855135, 102855332], [102866595, 102866663], [102877461, 102877550], [102894734, 102894918], [102912790, 102912898], [102917070, 102917225], [102958194, 102958441]], "strand": -1, "transcript": "NM_001354304", "txend": 102958441, "txstart": 102836888}], "exons_hg19": [{"cdsend": 103310908, "cdsstart": 103232952, "chr": "12", "position": [[103230666, 103232996], [103234177, 103234293], [103237423, 103237557], [103238113, 103238209], [103240672, 103240729], [103245464, 103245534], [103246592, 103246728], [103248913, 103249110], [103260373, 103260441], [103271239, 103271328], [103288512, 103288696], [103306568, 103306676], [103310848, 103311022]], "strand": -1, "transcript": "NM_000277", "txend": 103311022, "txstart": 103230666}, {"cdsend": 103310908, "cdsstart": 103232952, "chr": "12", "position": [[103230666, 103232996], [103234177, 103234293], [103237423, 103237557], [103238113, 103238209], [103240672, 103240729], [103245464, 103245534], [103246592, 103246728], [103248913, 103249110], [103260373, 103260441], [103271239, 103271328], [103288512, 103288696], [103306568, 103306676], [103310848, 103311003], [103351972, 103352219]], "strand": -1, "transcript": "NM_001354304", "txend": 103352219, "txstart": 103230666}], "generif": [{"pubmed": 11172645, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 11385716, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 11524738, "text": "Sixteen different mutations have been detected, two mutations were found at unexpectedly high frequencies, E280K and R261Q."}, {"pubmed": 11678552, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 11708866, "text": "The spectrum of PAH gene mutations in Sicily reflects the complex demographic history of this island at the crossroad of prehistoric and historical migrations in the Mediterranean sea."}, {"pubmed": 11718561, "text": "X ray cystallography of the catalytic domain in its catalytically active Fe(II) form and binary complex with tetrahydrobiopterin ytic domain"}, {"pubmed": 11855940, "text": "Tetrahydrobiopterin regulates gene's expression in phenylalanine hydroxylase deficiency."}, {"pubmed": 11935335, "text": "Identification and characterization of a novel liver-specific enhancer of the human phenylalanine hydroxylase gene."}, {"pubmed": 12056888, "text": "Analysis of differential scanning calorimetry thermograms shows that thermal denaturation of PAH occurs in three stages: unfolding of the four regulatory domains; unfolding of two (out of the four) catalytic domains; and irreversible protein denaturation."}, {"pubmed": 12096915, "text": "Structural comparison of bacterial and human iron-dependent phenylalanine hydroxylases: similar fold, different stability and reaction rates."}, {"pubmed": 12126628, "text": "crystal structure of the ternary complex of the catalytic domain of human phenylalanine hydroxylase with tetrahydrobiopterin and 3-(2-thienyl)-L-alanine"}, {"pubmed": 12173030, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12173030, "text": "the mutation spectrum in the Republic of Ireland"}, {"pubmed": 12185072, "text": "determination of molecular basis for the effects of phosphorylation on the catalytic efficiency and enzyme stability"}, {"pubmed": 12200907, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12210276, "text": "Genetic evaluation of the family members of subjects with the PAH K274E mutation showed that all individuals with the K274E mutation also exhibited the PAH L321L polymorphism in the catalytic domain of the PAH enzyme."}, {"pubmed": 12379147, "text": "Both the on- and off-rates for the conformational transition were biphasic, which is interpreted in terms of a difference in the energy barrier and the rate by which the two domains (catalytic and regulatory) undergo a conformational change."}, {"pubmed": 12603326, "text": "study of deamidation of labile asparagine residues in the autoregulatory sequence"}, {"pubmed": 12603331, "text": "studies on the regulatory properties of the pterin cofactor and dopamine bound at the active site"}, {"pubmed": 12640344, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12649065, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 12653545, "text": "To investigate further the involvement of Cys237 and Arg68 in the activation of the enzyme, we have prepared mutants of hPAH at these positions, with substitutions of different charge and size."}, {"pubmed": 12655545, "text": "A review of studies of PAH gene mutations causing hyper-phenylalaninemia points in particular to a prevalent general mechanism that appears to play a major role in the pathogenicity of many PAH mutations."}, {"pubmed": 12655546, "text": "Two catalytic mutations (Y277D and E280K) and two severe structural defects (IVS10-11G>A and L311P) have been found to abolish PAH specific activity."}, {"pubmed": 12655552, "text": "Two novel amino acid subsittutions, L249P in exon 7 and F402L in exon 12 and one nucleotide substitution 912T>C in intron 8 of the PAH gene in Phenylketonuria families."}, {"pubmed": 12765842, "text": "mutations and polymorphisms of phenylalanine hydroxylase are associated with phenylketonuria"}, {"pubmed": 12777691, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 12782966, "text": "Variation is not a highly penetrant autosomal dominant susceptibility locus for mood disorder in families."}, {"pubmed": 12833401, "text": "Parental attitudes regarding newborn screening of PKU were compiled and evaluated."}, {"pubmed": 14568534, "text": "Results describe the crystal structures of the catalytic domain of human phenylalanine hydroxylase in complex with 6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin and 3-(2-thienyl)-L-alanine or L-norleucine at 2.0A resolution."}, {"pubmed": 14654659, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15060071, "text": "mutant forms revealed a variably reduced global conformational stability compared with wild-type human PAH, as measured by thermal denaturation and limited proteolysis"}, {"pubmed": 15135070, "text": "the denatured state properties of the AAAHs (TH, TPH and PAH) contribute significantly to the stability of these enzymes and their tolerance towards missense mutations"}, {"pubmed": 15192831, "text": "Observational study of genotype prevalence and genetic testing. (HuGE Navigator)"}, {"pubmed": 15300621, "text": "Eleven mutations and 3 polymorphisms in PAH gene were found in 40 phenylketonuria (PKU) patients."}, {"pubmed": 15300621, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15313177, "text": "Hence, generation of H(2)O(2) by UVB can activate epidermal PAH leading to an increased L-tyrosine pool for melanogenesis."}, {"pubmed": 15459954, "text": "seven mild PKU mutations resulted in catalytic defects; I65T, R68S, P244L, and most probably A309V, showed reduced binding affinity for tetrahydrobiopterin"}, {"pubmed": 15464430, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15556637, "text": "Tetrahydrobopterin protects PAH activity in vitro and has implications for phenylketonurias."}, {"pubmed": 15730960, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15793771, "text": "Study demonstrated the variety of the mutation type PAH gene of PKU in Inner Mongolia population, and confirmed that R243Q, Y356X, Y204C were the hot spots of PAH gene mutation."}, {"pubmed": 15917086, "text": "Tyr325 appears to have an important role ensuring stoichiometric binding of iron, correct geometry of the complexes with substrate and cofactor and, consequently, a right coupling efficiency of the PAH reaction."}, {"pubmed": 16086286, "text": "Hyperphenylalaninemia may be caused by deficiency of Phe hydroxylase or by deficiency of co-factor BH(4)."}, {"pubmed": 16256386, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16402341, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16545551, "text": "both subunits of phenylalanine hydroxylase were expressed and that the purified heteroallelic enzymes, were catalytically active"}, {"pubmed": 16755493, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16765994, "text": "Results showed that both arginine amino acid and exon 7 is of great significance with regards to the structure and function of the enzyme."}, {"pubmed": 16917891, "text": "A recurrent mutation (c.1222C>T) within the PAH gene is explained by spontaneous methylation-mediated deamination of a CpG dinucleotide in a hypermutable codon."}, {"pubmed": 16935936, "text": "Both 7(R)- and 7(S)BH4 function as poor cofactors for PAH, whereas only 7(S)BH4 acts as a potent competitive inhibitor"}, {"pubmed": 17096675, "text": "In phenylalanine hydroxylase deficiency, mutations were identified in 240/249 PAH alleles (detection rate: 96.4%). Of 60 gene variants, the most frequent were p.R261Q (15.7% of alleles), p.A403V (11.6% of alleles) and c.1066-11G > A (8.8% of alleles)."}, {"pubmed": 17502162, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 17557229, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17627389, "text": "Mutations in the regulatory domain responded to tetrahydrobiopterin even in patients with classical phenylketonuria."}, {"pubmed": 17630668, "text": "A PAH mutational analysis in phenylketonuria patients in two large old order Amish settlements."}, {"pubmed": 17633563, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17924342, "text": "The prediction of the energetic impact on PAH native-state stability of 318 PKU-associated missense mutations, was studied."}, {"pubmed": 18184144, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18184144, "text": "The birth prevalence of PKU in populations of European, South Asian, and sub-Saharn African ancestry living in South East England is reported."}, {"pubmed": 18247293, "text": "the pathogenic effect and the correlation between the genotype and phenotype of the 4 novel missense mutations (G247S, E280G, P362T and A434D) of phenylalanine hydroxylase gene (PAH)"}, {"pubmed": 18294361, "text": "Among 159 Israeli patients (Jews, Muslim and Christian Arabs and Druze) with Hyperphenylalaninemia, in whom at least one of the mutations was characterized, a total of 43 different mutations were detected, including seven novel ones."}, {"pubmed": 18299955, "text": "mutation spectrum of the PAH gene in phenylketonuria patients in Israel is described, along with a discussion on genotype-phenotype correlations"}, {"pubmed": 18346471, "text": "Data demonstrate the disease-causing nature of the five novel phenylalanine hydroxylase proteins variants."}, {"pubmed": 18374504, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18387838, "text": "Three PKU-causing single exon deletions PAH are present in around 2-3% of Polish phenylketonuria patients."}, {"pubmed": 18447256, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18538294, "text": "The impact of ten PAH gene mutations identified in patients with BH(4) responsivess on enzyme kinetics, stability and protein conformation was investigated."}, {"pubmed": 18769885, "text": "Glycerol and trimethylamine N-oxide (TMAO)rescue of enzyme activity results from a direct stabilizing effect of the newly synthesized mutant hPAH enzymes."}, {"pubmed": 18798839, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18798839, "text": "The most common mutations in PAH were V388M (21.2), R261Q (16.0%), IVS10-11G>A (15.3%), I65T (5.8%), IVS2+5G>C (5.8%), R252W (5.1%), IVS2+5G>A (4.5%), P281L (3.8%) & L348V (3.2%); these mutations correspond to 80% of PKU alleles in Gerais State, Brazil."}, {"pubmed": 18937047, "text": "Biochemical assessment of mutant PAH proteins, especially parameters involving interaction with BH(4) that impact protein folding, appear useful in clinical correlation"}, {"pubmed": 18937293, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18937293, "text": "These analyses suggest several associations at PAH with schizophrenia with consistent evidence for rs1522305."}, {"pubmed": 18956252, "text": "Genotype-phenotype correlation in patients with BH(4)-responsive PKU."}, {"pubmed": 18956252, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18985011, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18985011, "text": "Study shows that the allelic frequency of exon deletion or duplication is 9% (6/66) in Korean PKU patients, which suggests that these mutations may be frequent causes of PKU in Korean subjects."}, {"pubmed": 19036622, "text": "S-oxidation of S-carboxymethyl-L-cysteine was dramatically reduced by mutant PAH."}, {"pubmed": 19062537, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19062537, "text": "Predicting a clinical/biochemical phenotype for PKU/MHP patients with PAH gene mutations"}, {"pubmed": 19062542, "text": "Independent origin of rare Y168H mutation of human phenylalanine hydroxylase gene in Russia"}, {"pubmed": 19086053, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19099685, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19147918, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19147918, "text": "The mutation distribution of phenylketonuria in Xinjiang displayed a distinct ethnic pattern."}, {"pubmed": 19161120, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 19199246, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19199246, "text": "The study showed not only a distinct and conservative, but also a crossed and syncretic genetic characteristics in Xinjiang Uygur population."}, {"pubmed": 19268543, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19292873, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19292873, "text": "We sequenced the entire gene for phenylalanine hydroxylase in 51 unrelated hyperphenylalaninemia patients from Southern Italy"}, {"pubmed": 19360691, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19394257, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19444284, "text": "phenylalanine hydroxylase mutations are responsible for poor response to tetrahydrobiopterin in phenylketonuria patients."}, {"pubmed": 19485247, "text": "95% of mutations of the phenylalanine hydroxylase gene were identified in a group of 238 phenylketonuria-patients followed up in Krakow region."}, {"pubmed": 19629656, "text": "Missense p.S231F should be classified as a functionally null PAH gene mutation as it drastically reduces stability and activity of the PAH enzyme in vitro."}, {"pubmed": 19674121, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19786003, "text": "Results provide information on the distribution of phenylalanine hydroxylase mutations in phenylketonuria in the Mediterranean area."}, {"pubmed": 19915519, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19915519, "text": "The data presented in this study indicate that the total pool of mutant PAH alleles in phenylketonuria in Chinese Han population consisted of a small number of common mutations and a very high number of rare mutations."}, {"pubmed": 19938643, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20017307, "text": "Mutations were identified in 45/58 alleles (detection rate: 96.4%} of PAH in patients with phenylketonuria in China."}, {"pubmed": 20082265, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20140859, "text": "Mutations were found in all exons or flanking introns of the PAH gene except for exons 9 and 13."}, {"pubmed": 20187763, "text": "13 different mutations have been detected, which account for 75% of the total mutant alleles. Two mutations were found at high frequencies: IVS10-11G>A (19.3%) and P281L (19.3%), possibly due to consanguinity and genetic drift, among other factors."}, {"pubmed": 20187763, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20188615, "text": "3' splice site mutation c.168-2A>G resulted in activation of a cryptic 3' splice site that generated a premature termination codon leading to very low levels of mutant transcript, probably due to activation of nonsense-mediated decay (NMD) pathway"}, {"pubmed": 20457534, "text": "c.30C>G causes aberrant mRNA splicing in PAH in two different reporter minigenes and this is abolished if a preexisting flanking GGG triplet is disrupted."}, {"pubmed": 20468064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20667834, "text": "Activation of phenylalanine hydroxylase induces positive cooperativity toward the natural cofactor."}, {"pubmed": 20937381, "text": "Data indicate that PAH G46S mutation results in a N-terminal extension of alpha-helix 1 which perturbs the wild-type alpha-beta sandwich motif in the R-domain and promotes new intermolecular contacts, self-association and non-amyloid fibril formation."}, {"pubmed": 21154324, "text": "The mutation spectrum and frequency of the PAH gene of patients with phenylketonuria in Henan province were slightly different from those from other parts of China."}, {"pubmed": 21811977, "text": "mutations in exons 3, 6, 7, 11 and 12 of the phenylalanine hydroxylase gene in patients with phenylketonuria"}, {"pubmed": 21890392, "text": "The spectrum of phenylalanine hydroxylase (PAH) gene mutations upon investigating 35 index patients identified with hyperphenylalaninemia in Armenia, is presented."}, {"pubmed": 22333022, "text": "The mutations of phenylketonuria patients from Hebei Province are scattered throughout the PAH gene. Most of them are of single nucleotide substitutions, but large deletions are not rare."}, {"pubmed": 22513348, "text": "Disease-causing mutations were identified on 209 alleles of the phenylalanine hydroxylase gene."}, {"pubmed": 22526846, "text": "The five most prevalent PAH mutations found in patients were p.R408W, IVS12 + 1G>A, p.R261Q, p.R158Q and IVS2 + 5G>C."}, {"pubmed": 22698810, "text": "PAH exon 11 is vulnerable due to a weak 3' splice site."}, {"pubmed": 22763404, "text": "Eleven different mutations were found, with the most frequent mutation, IVS10-11G>A, accounting for 19% of Khorasan-Razavi PKU alleles."}, {"pubmed": 22808937, "text": "The p.G352fsdelG mutation in the PAH gene does not appear to be prevalent in the Moroccan population and would be responsible for only few cases of phenylketonuria."}, {"pubmed": 23074961, "text": "Phenylketonuria (PKU) associated multiple mutations in phenylalanine hydroxylase (PAH) gene were identified in Balto-Russian population studied."}, {"pubmed": 23220018, "text": "Thirteen different mutations were identified in the PAH gene in Lebanese patients with phenylalanine hydroxylase deficiency."}, {"pubmed": 23296088, "text": "A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics."}, {"pubmed": 23856132, "text": "Genotype-phenotype correlation of PAH gene mutations in phenylketonuria in a Syrian population."}, {"pubmed": 23898865, "text": "findings suggest that common genetic variations in Phenylalanine hydroxylase are associated with verbal memory in healthy adults."}, {"pubmed": 23932990, "text": "The observed phenotype is not always consistent with genotype predicting effect in Chinese phenylalanine hydroxylase deficiency patients."}, {"pubmed": 24048906, "text": "15 different mutations were found in 27 unrelated Kurdish PKU patients. IVS4 + 1G > C (c.441 + 1G > C) and IVS7 - 5 T > C (c.843 - 5 T > C) are novel mutations. PAH mutations differ between the Kermanshah province and other parts of Iran."}, {"pubmed": 24078561, "text": "125 new mutations were found in exons 6, 7 and 12 of PAH in patients with hyperphenylalaninemia."}, {"pubmed": 24130151, "text": "This is probably the first report of identification of a significantly low proportion of missense PAH mutations from PKU families and together with the presence of a high proportion of splice, insertion-deletion, and nonsense mutations."}, {"pubmed": 24350308, "text": "Analysis of the published data shows similar percentage of the \"BH4-responsive\" variants of a PAH gene in patients from other countries of Eastern Europe"}, {"pubmed": 24401910, "text": "In this study of the PAH mutation spectrum in the Taiwanese population, 139 alleles were identified including 34 different mutations."}, {"pubmed": 24510552, "text": "Twenty phenylalanine hydroxylase gene mutations were discovered."}, {"pubmed": 24510568, "text": "A total of 98 mutations were detected in 110 phenylalanine hydroxylase alleles."}, {"pubmed": 24606907, "text": "Two polymorphic variants of PAH appear to be risk factors for NSCL/P, rs7485331 and rs12425434 in a Polish population."}, {"pubmed": 24607329, "text": "lipoprotein synthesis in PAH-deficient children, particularly in PKU children, was suppressed in early life."}, {"pubmed": 24825084, "text": "We demonstrated the high expression of PAH and a large increase of PAH activity in differenciated liver progenitor cells."}, {"pubmed": 24941924, "text": "Mutational spectrum was presented for PAH gene in PAH deficiency patients from different parts of Mexico. New mutations were described."}, {"pubmed": 25449068, "text": "Mutations were detected in the exons and flaking introns of PAH gene of 44 families with classical phenylketonuria."}, {"pubmed": 25596310, "text": "We determined phenylalanine hydroxylase function of 30 frequent homozygous and compound heterozygous genotypes covering 55% of the study population."}, {"pubmed": 25750018, "text": "Combining in silico analysis and molecular dynamics simulations (in total 3 mus) we described the structural impact of the mutations, which allowed us to separate 32 out of 34 mutations between groups A and B."}, {"pubmed": 25863075, "text": "15 different mutations of phenylalanine hydroxylase gene were detected in patients with phenylketonuria."}, {"pubmed": 25863076, "text": "R241C, R408Q and Ex6-96A>G are the most common mutations in PAH in phenylalanine hydroxylase deficiency patients."}, {"pubmed": 25894915, "text": "This study identified one novel PAH variant-c.699C>G-and and tries to show a genotype-phenotype relationship also regarding BH4-responsiveness."}, {"pubmed": 25990862, "text": "Aberrant methylation is observed in leukocytes of PAH deficient phenylketonuria patients and is influenced by phenylalanine exposure."}, {"pubmed": 26025954, "text": "This study is the first report on tested population genetic structure using VNTR alleles at the PAH gene"}, {"pubmed": 26542770, "text": "In this study, we assigned the phenotypic outcome of three of the five novel mutations and furthermore six not previously classified mutations to one of the four PKU categories."}, {"pubmed": 26575882, "text": "mutation spectrum of the gene PAH in the Qinghai population was similar to that in other populations in North China"}, {"pubmed": 26600521, "text": "PAH gene mutation analysis combined with STR linkage analysis can provide rapid and accurate prenatal diagnosis for phenylketonuria families"}, {"pubmed": 26759449, "text": "Among phenylketonuria patients, some with autism at the time of evaluation, six mutations were identified: p.E280K, p.G352Vfs, IVS10nt11, p.I224T, p.R261Q, and p.R252W. Study found no correlation between autism and mutations affecting the phenylalanine hydroxylase gene, but the age of die"}, {"pubmed": 26803807, "text": "The co-expression of two distinct PAH variants revealed possible dominance effects (positive or negative) by one of the variants on residual PAH activity as a result of interallelic complementation."}, {"pubmed": 26919687, "text": "Studies involving co-expression of differently phenylalanine hydroxylase (PAH) alleles have shown that one variant form can influence the other when assembled into a tetramer and have effect on enzyme activity in vitro, and on BH4 responsiveness and PKU phenotype in patients carrying them. [review]"}, {"pubmed": 27049649, "text": "Data provide the structural evidence for a dietary I-phenylalanine (Phe) binding pocket at the subunit-subunit interface of a N-terminal regulatory domain (PAH-RD) dimer, and demonstrate that PAH-RD dimerization depends on Phe binding."}, {"pubmed": 27173423, "text": "PAH mutation analyses provided further support for genotype-phenotype correlations in patients with hyperphenylalaninemia. The high incidence of phenylketonuria in Nagasaki, the westernmost part of Japan, might be due to migration of people with PAH mutations from China and Korea, and geographic factors."}, {"pubmed": 27264808, "text": "The mutation spectrum of PAH gene in Henan seems to differ from that of other regions. Independent assortment of mutant alleles may result in a complex genotype-phenotype correlation."}, {"pubmed": 27308838, "text": "17 VUS (37%; 7 in ACADM, 9 in GALT, and 1 in PAH) were reclassified from uncertain (6 to benign or likely benign and 11 to pathogenic or likely pathogenic). We identified common types of missing information that would have helped make a definitive classification and categorized this information by ease and cost to obtain"}, {"pubmed": 27447460, "text": "Our study highlighted two novel promoter KLF1 and 3'-region C/EBPalpha motifs in the phenylalanine hydroxylase (PAH) gene which decrease transcription in vitro and, thus, could be considered as PAH expression modifiers."}, {"pubmed": 27620137, "text": "The results of the in vitro residual PAH activity have major implications, both for our understanding of genotype-phenotype correlations, and thereby existing inconsistencies, but also for the elucidation of the molecular basis of tetrahydrobiopterin (BH4) responsiveness."}, {"pubmed": 28389235, "text": "DNA methylated alleles of the phenylalanine hydroxylase promoter remodeled at elevated phenylalanine levels in newborns with hyperphenylalaninemia have been characterized."}, {"pubmed": 28604955, "text": "Phenylalanine hydroxylase gene mutations are associated with phenylketonuria."}, {"pubmed": 28653649, "text": "Our findings contribute to better understanding of structure and function of PAH mutated enzymes and optimal treatment of PKU patients carrying these mutations using BH4 supplementation."}, {"pubmed": 28676969, "text": "strong association between particular mutations and minihaplotypes could be useful for prenatal diagnosis and preimplantation genetic diagnosis in affected families"}, {"pubmed": 28982351, "text": "We obtained a PAH gene variant spectrum for the Northern Chinese population and devised a strategy for gene diagnosis using phenylketonuria pedigrees."}, {"pubmed": 29032371, "text": "PAH mutation was associated with hyperphenylalaninemia."}, {"pubmed": 29174366, "text": "Molecular diagnostics for DNAJC12 variants are thus mandatory in all patients in which deficiencies of PAH and BH4 are genetically excluded."}, {"pubmed": 29390883, "text": "Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China has been reported."}, {"pubmed": 29413232, "text": "a spectrum of PAH mutations complied from 35 PKU children who are all Chinese Han population from north Jiangsu, is reported in this study."}, {"pubmed": 29514280, "text": "We demonstrate that kinetically instable and aggregation-prone variant Pah proteins trap BH4, shifting the pool of free BH4 towards bound BH4. Interference of PAH protein misfolding with metabolite-based control of l-phenylalanine turnover suggests a mechanistic link between perturbation of protein homeostasis and disturbed regulation of metabolic pathways."}, {"pubmed": 29653233, "text": "three novel variants of the PAH gene, p.E178K (c.532G>A), p.V245M (c.733G>A), p.S250F (c.749C>T), showed impaired protein expression and enzyme activity."}, {"pubmed": 29684050, "text": "Report a novel intron 11 regulatory element, which is involved in exon 11 splicing, as revealed by the investigated pathogenic effect of variants c.1199+17G>A and c.1199+20G>C, identified in PKU patients. Both mutations cause exon 11 skipping in a minigene system."}, {"pubmed": 30037505, "text": "Mild phenylketonuria(PKU) variants (phenylalanine hydroxylase activity=40.2+/-7.6%; APV=2.8-6.6) were not significantly different from mild hyperphenylalaninemia, but there was a difference (p<.048) compared with classic PKU phenotypes."}, {"pubmed": 30050108, "text": "This study provides further support for the hypothesis that the PAH genotype is the main factor that determines the phenotype of phenylketonuria."}, {"pubmed": 30159852, "text": "this is the most comprehensive molecular genetics study of Phenylketonuria (PKU) in Iran, identifying 100 distinct mutations in the phenylalanine hydroxylase (PAH) gene, including 15 previously unreported mutations."}, {"pubmed": 30287685, "text": "regulatory ACT domain of human phenylalanine hydroxylase"}, {"pubmed": 30459323, "text": "Phenylalanine hydroxylase mutations in the phenylalanine hydroxylase deficiency patients in China."}, {"pubmed": 30512147, "text": "In phenylketonuria patients from Henan Province, 195 point variants and 3 large fragment deletions were detected. Most of the variants were located in exons 7, 11, 3 and 6. Missense variations were most common."}, {"pubmed": 30747360, "text": "that p.Arg53His and p.Gln419Arg of PAH gene were correlated with mild hyperphenylalaninemia"}, {"pubmed": 31102715, "text": "Data reported 9 newly discovered PAH variants, further enriched the spectrum of PAH variants and helped to better understand the genotype-phenotype correlation in PKU patients."}, {"pubmed": 31382905, "text": "Phenylketonuria (PKU) is an autosomal recessive genetic disease, caused by the phenylalanine hydroxylase (PAH) deficiency in the metabolic pathway."}, {"pubmed": 31703125, "text": "study of variants of the PAH gene in patients with phenylketonuria from Jiangxi province"}, {"pubmed": 31703126, "text": "A novel variant of the PAH gene (L227M) has been detected in children affected with hyperphenylalaninemia from Quanzhou area of Fujian province"}, {"pubmed": 31923802, "text": "Population and evolutionary genetics of the PAH locus to uncover overdominance and adaptive mechanisms in phenylketonuria: Results from a multiethnic study."}, {"pubmed": 32069237, "text": "Genetic variants of the phenylalanine hydroxylase gene in patients with phenylketonuria in the northeast of Iran."}, {"pubmed": 32074228, "text": "IDENTIFICATION OF MUTATIONS IN THE PAH GENE IN PKU PATIENTS IN THE STATE OF MATO GROSSO."}, {"pubmed": 32893076, "text": "Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Shanxi province."}, {"pubmed": 33051130, "text": "A novel Pah-exon1 deleted murine model of phenylalanine hydroxylase (PAH) deficiency."}, {"pubmed": 33055427, "text": "A porcine model of phenylketonuria generated by CRISPR/Cas9 genome editing."}, {"pubmed": 33161754, "text": "Variants of the phenylalanine hydroxylase gene in neonates with phenylketonuria in Hainan, China."}, {"pubmed": 33260674, "text": "E3 Ubiquitin Ligase APC/C(Cdh1) Regulation of Phenylalanine Hydroxylase Stability and Function."}, {"pubmed": 33395657, "text": "PREVALENCE OF PAH MUTATIONS IN GEORGIAN PKU PATIENTS COMPARED TO MOST FREQUENT PAH MUTATIONS IN EUROPEAN POPULATIONS."}, {"pubmed": 33491267, "text": "In silico screening and molecular dynamics simulation of deleterious PAH mutations responsible for phenylketonuria genetic disorder."}, {"pubmed": 33625639, "text": "Spectrum of PAH gene mutations in 1547 phenylketonuria patients from Iran: a comprehensive systematic review."}, {"pubmed": 33677757, "text": "Molecular characterization of Thai patients with phenylalanine hydroxylase deficiency and in vitro functional study of two novel PAH variants."}, {"pubmed": 33766497, "text": "Effect of BH4 on blood phenylalanine and tyrosine variations in patients with phenylketonuria."}, {"pubmed": 33970801, "text": "Identifying and elucidating the roles of Y198N and Y204F mutations in the PAH enzyme through molecular dynamic simulations."}, {"pubmed": 34353949, "text": "A noncoding RNA modulator potentiates phenylalanine metabolism in mice."}, {"pubmed": 34360752, "text": "Systematic Modification and Evaluation of Enzyme-Loaded Chitosan Nanoparticles."}, {"pubmed": 34704413, "text": "Follow-up of two newborns with c.158G>A (p.Arg53His) mutation in gene and assessment of the site function."}, {"pubmed": 34828281, "text": "An Updated PAH Mutational Spectrum of Phenylketonuria in Mexican Patients Attending a Single Center: Biochemical, Clinical-Genotyping Correlations."}, {"pubmed": 35023679, "text": "Frequency of PAH Mutations Among Classic Phenylketon Urea Patients in Mazandaran and Golestan Provinces, North of Iran."}, {"pubmed": 35339094, "text": "The pathogenicity classification of PAH gene variants in the Iranian population."}, {"pubmed": 35355500, "text": "Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Turkey."}, {"pubmed": 35405047, "text": "An update of the mutation spectrum of phenylalanine hydroxylase (PAH) gene in the population of Turkey."}, {"pubmed": 35952926, "text": "Newborn screening and genetic features of patients with hyperphenylalaninemia in a southern Chinese population."}, {"pubmed": 35987969, "text": "Deubiquitinase USP19 extends the residual enzymatic activity of phenylalanine hydroxylase variants."}, {"pubmed": 36104584, "text": "Characterization of phenylalanine hydroxylase gene variants and analysis of genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Fujian Province, Southeastern China."}, {"pubmed": 36849017, "text": "Deep Intronic PAH Variants Explain Missing Heritability in Hyperphenylalaninemia."}, {"pubmed": 37098607, "text": "The spectrum of phenylalanine hydroxylase variants and genotype-phenotype correlation in phenylketonuria patients in Gansu, China."}, {"pubmed": 37237386, "text": "Identification of deep intronic variants of PAH in phenylketonuria using full-length gene sequencing."}, {"pubmed": 37257178, "text": "Identification of Variants Underlying Phenylalanine Hydroxylase Deficiency in Saudi Arabia."}, {"pubmed": 37553307, "text": "Mutation Characteristics of Phenylalanine Hydroxylase Gene in Children with Phenylketonuria in Yinchuan City."}, {"pubmed": 38436318, "text": "[In vitro expression and functional analyses of the mutants p.R243Q, p.R241C and p.Y356X of the human phenylalanine hydroxylase]."}, {"pubmed": 38448014, "text": "[Analysis of pathogenicity and genotype-phenotype correlation of the c.158G>A variant of phenylalanine hydroxylase gene]."}, {"pubmed": 38706300, "text": "Comprehensive analyses of phenylalanine hydroxylase variants and phenotypic characteristics of patients in the eastern region of Turkiye."}, {"pubmed": 38731816, "text": "Genetic Landscape and Clinical Features of Hyperphenylalaninemia in North Ossetia-Alania: High Frequency of P281L and P211T Genetic Variants in the PAH Gene."}], "genomic_pos": {"chr": "12", "end": 102958410, "ensemblgene": "ENSG00000171759", "start": 102836889, "strand": -1}, "genomic_pos_hg19": {"chr": "12", "end": 103352188, "start": 103230663, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0006559", "qualifier": "involved_in", "term": "L-phenylalanine catabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006571", "qualifier": "involved_in", "term": "tyrosine biosynthetic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0008652", "pubmed": 3856322, "qualifier": "involved_in", "term": "amino acid biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019293", "qualifier": "involved_in", "term": "tyrosine biosynthetic process, by oxidation of phenylalanine"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0042423", "pubmed": 2872999, "qualifier": "involved_in", "term": "catecholamine biosynthetic process"}], "CC": {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004505", "qualifier": "enables", "term": "phenylalanine 4-monooxygenase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004505", "pubmed": 20667834, "qualifier": "enables", "term": "phenylalanine 4-monooxygenase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005506", "qualifier": "enables", "term": "iron ion binding"}]}, "homologene": {"genes": [[6239, 174401], [7165, 1276381], [7227, 38871], [7955, 378962], [8364, 613076], [9031, 408024], [9544, 698696], [9598, 741097], [9606, 5053], [9615, 475446], [9913, 510583], [10090, 18478], [10116, 24616]], "id": 234}, "interpro": [{"desc": "Aromatic amino acid hydroxylase", "id": "IPR001273", "short_desc": "ArAA_hydroxylase"}, {"desc": "ACT domain", "id": "IPR002912", "short_desc": "ACT_dom"}, {"desc": "ACT-like domain", "id": "IPR045865", "short_desc": "ACT-like_dom_sf"}, {"desc": "Aromatic amino acid hydroxylase, C-terminal", "id": "IPR019774", "short_desc": "Aromatic-AA_hydroxylase_C"}, {"desc": "Aromatic amino acid monoxygenase, C-terminal domain superfamily", "id": "IPR036329", "short_desc": "Aro-AA_hydroxylase_C_sf"}, {"desc": "Aromatic amino acid hydroxylase superfamily", "id": "IPR036951", "short_desc": "ArAA_hydroxylase_sf"}, {"desc": "Aromatic amino acid hydroxylase, iron/copper binding site", "id": "IPR018301", "short_desc": "ArAA_hydroxylase_Fe/CU_BS"}, {"desc": "Phenylalanine-4-hydroxylase, tetrameric form", "id": "IPR005961", "short_desc": "Phe-4-hydroxylase_tetra"}, {"desc": "Tyrosine 3-monooxygenase-like", "id": "IPR019773", "short_desc": "Tyrosine_3-monooxygenase-like"}, {"desc": "Eukaryotic phenylalanine-4-hydroxylase, catalytic domain", "id": "IPR041912", "short_desc": "Euk_PheOH_cat"}], "ipi": ["IPI00017579", "IPI01022545", "IPI01022733"], "map_location": "12q23.2", "name": "phenylalanine hydroxylase", "other_names": ["phe-4-monooxygenase", "phenylalanine 4-monooxygenase", "phenylalanine-4-hydroxylase"], "pantherdb": {"HGNC": "8582", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "97473", "ortholog_type": "LDO", "panther_family": "PTHR11473", "taxid": 10090, "uniprot_kb": "P16331"}, {"RGD": "3248", "ortholog_type": "LDO", "panther_family": "PTHR11473", "taxid": 10116, "uniprot_kb": "P04176"}, {"Ensembl": "ENSGALG00000012754", "ortholog_type": "LDO", "panther_family": "PTHR11473", "taxid": 9031, "uniprot_kb": "Q6PKI8"}, {"ZFIN": "ZDB-GENE-031006-2", "ortholog_type": "LDO", "panther_family": "PTHR11473", "taxid": 7955, "uniprot_kb": "Q7SYH6"}, {"WormBase": "WBGene00000240", "ortholog_type": "LDO", "panther_family": "PTHR11473", "taxid": 6239, "uniprot_kb": "P90925"}, {"FlyBase": "FBgn0001208", "ortholog_type": "LDO", "panther_family": "PTHR11473", "taxid": 7227, "uniprot_kb": "P17276"}, {"dictyBase": "DDB_G0278781", "ortholog_type": "LDO", "panther_family": "PTHR11473", "taxid": 352472, "uniprot_kb": "Q54XS1"}], "uniprot_kb": "P00439"}, "pathway": {"humancyc": {"id": "PHENYLALANINE-DEG1-PWY", "name": "phenylalanine degradation/tyrosine biosynthesis"}, "kegg": [{"id": "hsa00360", "name": "Phenylalanine metabolism - Homo sapiens (human)"}, {"id": "hsa00400", "name": "Phenylalanine, tyrosine and tryptophan biosynthesis - Homo sapiens (human)"}, {"id": "hsa00790", "name": "Folate biosynthesis - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-2160456", "name": "Phenylketonuria"}, {"id": "R-HSA-5668914", "name": "Diseases of metabolism"}, {"id": "R-HSA-71291", "name": "Metabolism of amino acids and derivatives"}, {"id": "R-HSA-8963691", "name": "Phenylalanine and tyrosine metabolism"}, {"id": "R-HSA-8964208", "name": "Phenylalanine metabolism"}], "smpdb": [{"id": "SMP00008", "name": "Phenylalanine and Tyrosine Metabolism"}, {"id": "SMP00206", "name": "Phenylketonuria"}, {"id": "SMP00369", "name": "Tyrosinemia Type 2 (or Richner-Hanhart syndrome)"}, {"id": "SMP00370", "name": "Tyrosinemia Type 3 (TYRO3)"}], "wikipathways": [{"id": "WP550", "name": "Biogenic Amine Synthesis"}, {"id": "WP706", "name": "Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways"}]}, "pdb": ["1DMW", "1J8T", "1J8U", "1KW0", "1LRM", "1MMK", "1MMT", "1PAH", "1TDW", "1TG2", "2PAH", "3PAH", "4ANP", "4PAH", "5FII", "5PAH", "6HPO", "6HYC", "6N1K", "6PAH"], "pfam": ["PF00351", "PF01842"], "pharmgkb": "PA32911", "pharos": {"target_id": 9923, "tdl": "Tclin"}, "pir": "A00508", "prosite": ["PS51410", "PS51671"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF253679", "relationship": "is"}, {"id": "GNF253680", "relationship": "is"}, {"id": "GNF253681", "relationship": "is"}, {"id": "GNF253682", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF047155", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF087285", "relationship": "is"}, {"id": "GNF087286", "relationship": "is"}, {"id": "GNF087287", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF050518", "relationship": "is"}, {"id": "GNF055281", "relationship": "is"}, {"id": "GNF059890", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF065913", "relationship": "is"}, {"id": "GNF065914", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF010831", "relationship": "is"}, "GNF_mm-kinase_lenti-shRNA": {"id": "GNF290328", "relationship": "is"}, "GNF_mm-kinase_plasmid-shRNA": {"id": "GNF077760", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF095158", "relationship": "is"}, {"id": "GNF134815", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1", "NG_008690.2"], "protein": ["NP_000268.1", "NP_001341233.1", "XP_016874859.1", "XP_054228125.1"], "rna": ["NM_000277.3", "NM_001354304.2", "XM_017019370.2", "XM_054372150.1"], "translation": [{"protein": "NP_001341233.1", "rna": "NM_001354304.2"}, {"protein": "XP_016874859.1", "rna": "XM_017019370.2"}, {"protein": "XP_054228125.1", "rna": "XM_054372150.1"}, {"protein": "NP_000268.1", "rna": "NM_000277.3"}]}, "reporter": {"HG-U133_Plus_2": ["205719_s_at", "209986_at", "217583_at", "242375_x_at", "244742_at"], "HG-U95Av2": "33701_at", "HG-U95B": "42519_at", "HTA-2_0": "TC12001892.hg.1", "HuEx-1_0": ["3468473", "3468562", "4053715"], "HuGene-1_1": "7965884", "HuGene-2_1": "16769270"}, "retired": 101929036, "summary": "This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].", "symbol": "PAH", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1418251"}, "unigene": ["Hs.603740", "Hs.560019", "Hs.703025"], "uniprot": {"Swiss-Prot": "P00439", "TrEMBL": ["J3KND8", "F8W0A0", "F8W1D4", "A0A0U1RQI3", "A0A0U1RQY4"]}, "wikipedia": {"url_stub": "Phenylalanine hydroxylase"}}